Actuate Therapeutics
ACTU1.1708.33% ( +0.090 )
Forecast & Rating4 analysts currently cover Actuate Therapeutics, of which 4 give a positive rating. The average price target is $9.98, about 752.8% upside from the current price of $1.17. Coverage is limited, so the data is for reference only. Data as of Jun 10, 2026; this does not constitute investment advice.
Jun 10, 2026Price forecast
$9.98752.78%
Forecast & RatingStrong buy
4analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast baselineJul 29, 2026
Forecast met0.0%
Stock price$1.17
Average forecast price$25.0
Highest forecast price$35
Lowest forecast price$20
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.